Skip to main content
Premium Trial:

Request an Annual Quote

Mandar Kulkarni

Cancer Genetics has appointed Mandar Kulkarni chief technology officer of Cancer Genetics, India. Kulkarni will direct efforts at expanding CG India's technology programs and initiatives with a focus on accelerating development and innovation. He will report to Cancer Genetics CEO Panna Sharma. Kulkarni joins the company from Sandor Lifesciences where he was head of molecular biology and genomics. He was also a senior scientist at M/Z Diagnostics.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more